Last reviewed · How we verify
NCT02797548: ASSURE-DES
Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery
Phase 4 trial testing Aspirin only in Antiplatelet Drugs in 1,010 participants. Completed in 31 May 2024.
31 May 2024
Quick facts
| Lead sponsor | Jung-min Ahn |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 1,010 |
| Start date | 16 March 2017 |
| Primary completion | 31 May 2024 |
| Estimated completion | 31 May 2024 |
| Sites | 35 locations across Turkey (Türkiye), South Korea, India |
Drugs / interventions tested
- Aspirin only — full drug profile →
- No antiplatelet therapy — full drug profile →
Conditions studied
- Antiplatelet Drugs — all drugs for Antiplatelet Drugs →
Sponsor
Jung-min Ahn — full company profile →
Who can join
19 and older, any sex, with Antiplatelet Drugs. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the safety and effectiveness of perioperative antiplatelet therapy in patients with drug-eluting stent undergoing non-cardiac surgery.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery.
Lewis SR, Pritchard MW, Schofield-Robinson OJ, Alderson P, et al · · 2018 · cited 29× · PMID 30019463 · DOI 10.1002/14651858.cd012584.pub2 -
Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery.
Kang DY, Lee SH, Lee SW, Lee CH, et al · · 2024 · cited 6× · PMID 39217573 · DOI 10.1016/j.jacc.2024.08.024
Verify or expand the search:
- PubMed search for NCT02797548
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Antiplatelet Drugs
Currently open trials in the same condition.
- NCT06451198 — IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome · Phase 4 · recruiting
Other Jung-min Ahn trials
Trials by the same sponsor.
- NCT06676280 — ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography · Phase 4 · recruiting
- NCT05044273 — Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent · recruiting
- NCT05043948 — Genome-wide Association Study of Development of Collateral Circulation for Patients With Coronary or Peripheral Artery D · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02797548 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jung-min Ahn
- Last refreshed: 5 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02797548.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing